Navigation Links
[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: IMMU, KYUS
Date:10/16/2008

NEW YORK, Oct. 16 /PRNewswire-FirstCall/ -- Wall St. Network's 3-Minute Press Show is a daily program hosted by WSN reporter Tracee Tolentino that features in-depth interviews with public company executives on their company and most recent press releases.

The show is designed to provide viewers with insight into a company's latest news, and its impact on the company's growth.
Shows air Monday through Friday at:

http://tv.wallst.net/3-min-press/3-min-press.php

The following executives were interviewed on today's show:

Cynthia Sullivan, President and CEO for Immunomedics, Inc. (Nasdaq: IMMU). To view this clip in its entirety, visit:

http://www.tv.wallst.net/r/3-minute-press/C-Sullivan-IMMU-ND/299/1181. Ask Cynthia Sullivan a question, post a comment on her profile page, and join her financial social network today at:

http://my.wallst.net/C-Sullivan-IMMU-ND

Steve Eversole, CEO for Kentucky USA Energy, Inc. (OTC Bulletin Board: KYUS). To view this clip in its entirety, visit:

http://www.tv.wallst.net/r/3-minute-press/S-Eversole-KYUS-BB/299/1180. Ask Steve Eversole a question, post a comment on his profile page, and join his financial social network today at:

http://my.wallst.net/S-Eversole-KYUS-BB

About WallStreet Direct, Inc.

WallStreet Direct, Inc. operates WallSt.net (http://www.wallst.net), a leading source of up-to-the-minute business news, comprehensive financial tools and original multimedia content for the investment community. In addition to WallSt.net, WallStreet Direct owns and operates WallStRadio (http://radio.wallst.net), an online hub for business podcasts from well-known business news personalities and publishers, and WallStTV (http://tv.wallst.net), a hub for business and finance video content. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit
http://www.wallst.net/disclaimer/disclaimer.php.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO)

Contact:

WallStreet Direct, Inc.

800-4-WALLST


'/>"/>
SOURCE WallStreet Direct, Inc./Kentucky USA Energy,Inc./Immunomedics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. [video] Edward Spink, CEO of TurboSonic Technologies, Inc. Discusses Contract With Biofuel Producer in Exclusive Interview on WallSt.nets 3-Minute Press Show
2. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
3. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
4. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
5. [video] Dr. Tony Milici, Chairman and CEO of GeneThera, Inc., Discusses Worldwide Rights to E.Coli Vaccine on WallSt.nets 3-Minute Press Show
6. CompareNetworks Media Group Delivers CME/CE Through Acuity Medical Education
7. Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hill Press Conference
8. Palladian Muscular Skeletal Health (formerly Prism Health Networks) to Promote Collaborative, Expanded Practice Model at Major Insurance Conference in June
9. Featured Stocks on Todays Edition of WallSt.nets 3-Minute Press Show: BFNH, BKYI, RBCL
10. Featured Stocks on Todays Edition of WallSt.nets 3-Minute Press Show: NPHC, PECD, PNRR
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Feb. 24, 2017 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced its unaudited financial results for the third quarter ... December 31, 2016. Third Quarter of Fiscal ... quarter of fiscal 2017 increased by 18.6% to RMB200.9 ...
(Date:2/24/2017)... Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a ... its financial results for the fourth quarter and fiscal year ... Total sales in the fourth quarter ... by 13.6% in USD terms to $77.6 million from $68.3 ... Gross profit increased by 13.3% to $46.8 million from $41.3 ...
(Date:2/24/2017)...  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company ... Opinion Leader event to highlight new clinical data that ... at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the ... held in-person and via live webcast on Tuesday, February ... at the Lotte New York Palace Hotel in ...
Breaking Biology Technology:
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... by 2021 from $8.3 billion in 2016 at a ... to 2021. Report Includes - An overview of ... market trends, with data from 2015 and 2016, and ... - Segmentation of the market on the basis of ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
Breaking Biology News(10 mins):